Mennini, Francesco Saverio, Martina Paoletti, Chiara Bini, Andrea Marcellusi, Marco Falcone, and Massimo Andreoni. “Cost-Utility Analysis of ceftolozane/Tazobactam Vs Meropenem in Patients With Hospital-Acquired Pneumonia (HABP) or Ventilator-Associated Pneumonia (VABP)”. Global and Regional Health Technology Assessment 9, no. 1 (April 7, 2022): 45–57. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/2287.